|Bid||0.1750 x 400000|
|Ask||0.1850 x 1960600|
|Day's range||0.1700 - 0.1800|
|52-week range||0.1150 - 0.3050|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||N/A|
|Earnings date||22 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Prescient Therapeutics Limited ( ASX:PTX ) shareholders might be concerned after seeing the share price drop 27% in the...
Under the guidance of CEO Steven Yatomi-Clarke, Prescient Therapeutics Limited ( ASX:PTX ) has performed reasonably...